MobileMedMinder: A Networked Aide for Medication Compliances
Sponsor
University of Maryland, Baltimore (Other)
Overall Status
Completed
CT.gov ID
NCT01597583
Collaborator
Limaging (Other)
34
1
2
25
1.4
Study Details
Study Description
Brief Summary
The main aim of this study is to conduct a randomized control trial to compare MobileMedMinder, a mobile phone based medication reminder software product, with currently accepted and empirically supported methods for increasing medication compliance through reminders and tracking.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Study Design
Study Type:
Interventional
Actual Enrollment
:
34 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
MobileMedMinder: A Networked Aide for Medication Compliances
Study Start Date
:
Nov 1, 2011
Actual Primary Completion Date
:
Dec 1, 2013
Actual Study Completion Date
:
Dec 1, 2013
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: Use of MobileMedMinder
|
Behavioral: Use of MobileMedMinder
Use of an intervention to remind patients to take their medications.
|
No Intervention: Usual care
|
Outcome Measures
Primary Outcome Measures
- Compliance [3 months]
Pill counts will be used to assess compliance
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
- Taking beta blockers, ACE or ARB, and hydralazine for treatment of HF.
Exclusion Criteria:
-
Inability to understand informed consent
-
Inability to read and understand English
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | University of Maryland | Baltimore | Maryland | United States | 21201 |
Sponsors and Collaborators
- University of Maryland, Baltimore
- Limaging
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Stephen Gottlieb,
Professor,
University of Maryland, Baltimore
ClinicalTrials.gov Identifier:
NCT01597583
Other Study ID Numbers:
- HP-00051021
First Posted:
May 14, 2012
Last Update Posted:
Mar 9, 2022
Last Verified:
Feb 1, 2022
Additional relevant MeSH terms: